SE448874B - Derivat av 4-amino-5-alkylsulfonyl-orto-anisamider, farmakologisk komposition och sett att framstella amiderna - Google Patents

Derivat av 4-amino-5-alkylsulfonyl-orto-anisamider, farmakologisk komposition och sett att framstella amiderna

Info

Publication number
SE448874B
SE448874B SE7900380A SE7900380A SE448874B SE 448874 B SE448874 B SE 448874B SE 7900380 A SE7900380 A SE 7900380A SE 7900380 A SE7900380 A SE 7900380A SE 448874 B SE448874 B SE 448874B
Authority
SE
Sweden
Prior art keywords
amino
methoxy
ethyl
pyrrolidylmethyl
formula
Prior art date
Application number
SE7900380A
Other languages
English (en)
Swedish (sv)
Other versions
SE7900380L (sv
Inventor
M Thominet
J Acher
J-C Monier
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of SE7900380L publication Critical patent/SE7900380L/xx
Publication of SE448874B publication Critical patent/SE448874B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE7900380A 1978-01-20 1979-01-16 Derivat av 4-amino-5-alkylsulfonyl-orto-anisamider, farmakologisk komposition och sett att framstella amiderna SE448874B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7801632A FR2415099A1 (fr) 1978-01-20 1978-01-20 Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Publications (2)

Publication Number Publication Date
SE7900380L SE7900380L (sv) 1979-07-21
SE448874B true SE448874B (sv) 1987-03-23

Family

ID=9203689

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7900380A SE448874B (sv) 1978-01-20 1979-01-16 Derivat av 4-amino-5-alkylsulfonyl-orto-anisamider, farmakologisk komposition och sett att framstella amiderna
SE8603773A SE460968B (sv) 1978-01-20 1986-09-09 Mellanfoerening, till framstaellning av terapeutiskt anvaendbara derivat av 4-amino-5-alkylsulfonyl-orto-anisamider, vilken utgoeres av 2-metoxi-4-amino-5-alkyltio- eller 2-metoxi-4-amino-5-alkylsulfonylbensoesyra

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8603773A SE460968B (sv) 1978-01-20 1986-09-09 Mellanfoerening, till framstaellning av terapeutiskt anvaendbara derivat av 4-amino-5-alkylsulfonyl-orto-anisamider, vilken utgoeres av 2-metoxi-4-amino-5-alkyltio- eller 2-metoxi-4-amino-5-alkylsulfonylbensoesyra

Country Status (42)

Country Link
US (2) US4294828A (OSRAM)
JP (1) JPS6049192B2 (OSRAM)
AR (2) AR221354A1 (OSRAM)
AT (1) AT377977B (OSRAM)
AU (1) AU528561B2 (OSRAM)
BE (1) BE872585A (OSRAM)
BG (2) BG31496A3 (OSRAM)
CA (1) CA1101430A (OSRAM)
CH (1) CH637927A5 (OSRAM)
CS (1) CS226181B2 (OSRAM)
CY (1) CY1201A (OSRAM)
DD (1) DD141520A5 (OSRAM)
DE (1) DE2901181C2 (OSRAM)
DK (1) DK158346C (OSRAM)
EG (1) EG14045A (OSRAM)
ES (2) ES476755A1 (OSRAM)
FI (1) FI71126C (OSRAM)
FR (1) FR2415099A1 (OSRAM)
GB (2) GB2083458B (OSRAM)
GR (1) GR64431B (OSRAM)
HK (1) HK12184A (OSRAM)
HU (1) HU179793B (OSRAM)
IE (1) IE47798B1 (OSRAM)
IL (1) IL56411A (OSRAM)
IN (1) IN150226B (OSRAM)
IT (1) IT1164655B (OSRAM)
LU (1) LU80786A1 (OSRAM)
MC (1) MC1232A1 (OSRAM)
MX (2) MX5793E (OSRAM)
NL (1) NL191707C (OSRAM)
NO (1) NO151320C (OSRAM)
NZ (1) NZ189378A (OSRAM)
OA (1) OA06156A (OSRAM)
PH (2) PH15725A (OSRAM)
PL (2) PL118151B1 (OSRAM)
PT (1) PT69068A (OSRAM)
RO (2) RO76393A (OSRAM)
SE (2) SE448874B (OSRAM)
SU (1) SU820659A3 (OSRAM)
YU (2) YU42172B (OSRAM)
ZA (1) ZA79219B (OSRAM)
ZM (1) ZM579A1 (OSRAM)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
NZ199080A (en) * 1980-12-12 1984-07-31 Beecham Group Ltd 2-alkoxy-4-amino-5-alkylsulphonyl-n-(3beta-(8-hydrocarbyl-8-azabicyclo (3,2,1)octyl))benzamides
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
FR2584401B1 (fr) * 1985-07-04 1987-11-20 Ile De France Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
US5227388A (en) * 1989-12-26 1993-07-13 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CN1791430A (zh) * 2003-05-16 2006-06-21 辉瑞产品公司 非典型抗精神病药物和gaba调节剂、抗惊厥药物或苯并二氮杂䓬类的治疗性组合
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
CA2565996A1 (en) * 2004-05-11 2005-11-17 Pfizer Products Inc. Combination of atypical antipsychotics and 5-ht1b receptor antagonists
CN101198323A (zh) * 2005-04-22 2008-06-11 惠氏公司 用于治疗或预防精神障碍的治疗组合
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
US7825156B2 (en) * 2007-02-02 2010-11-02 Copharms Method of treating bipolar depression with a benzamide derivative
JP2011526881A (ja) * 2008-06-25 2011-10-20 ファイザー・インク ジアリール化合物およびそれらの使用
US20100105755A1 (en) * 2008-09-12 2010-04-29 Auspex Pharmaceuticals, Inc. Substituted benzamide modulators of dopamine receptor
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
MX2011011833A (es) 2009-05-06 2012-01-27 Lab Skin Care Inc Composiciones de administración dérmica que comprenden complejos de partículas de fosfato de calcio-agente activo y métodos para utilizar las mismas.
CN101898991B (zh) * 2009-05-31 2013-09-25 江苏天士力帝益药业有限公司 一种(s)(-)-氨磺必利d-(-)-酒石酸盐的合成方法
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法
AU2016216578B2 (en) * 2010-03-11 2017-11-23 Acacia Pharma Limited The use of amisulpride as an anti-emetic
AU2014202535B2 (en) * 2010-03-11 2016-05-26 Acacia Pharma Limited The use of amisulpride as an anti-emetic
GB201004020D0 (en) 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
BR112012031959A2 (pt) 2010-06-17 2015-09-22 Lupin Ltd um processo aperfeiçoado para preparação de amisulpride
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103319384A (zh) * 2013-06-18 2013-09-25 苏州诚和医药化学有限公司 制备2-甲氧基-4-氨基-5-乙砜基苯甲酸的方法
CN103304453A (zh) * 2013-06-18 2013-09-18 苏州诚和医药化学有限公司 两步法合成2-甲氧基-4-氨基-5-乙砜基苯甲酸
CN103450058B (zh) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 一种氨磺必利酸的制备方法
CN104725292B (zh) * 2015-03-23 2017-07-25 湖北荆江源制药股份有限公司 一种(s)(‑)‑氨磺必利的制备方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
US11377421B2 (en) 2016-11-28 2022-07-05 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
MA46901A (fr) 2016-11-28 2019-10-02 Lb Pharmaceuticals Inc Agents psychotropes et leurs utilisations
CN106995397B (zh) * 2016-12-12 2020-01-14 河北医科大学 R-氨磺必利药用盐、制备方法、晶型及其用途
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
CA3088356A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
CN118593482A (zh) 2017-12-05 2024-09-06 赛诺维信制药公司 非外消旋混合物及其用途
CN110790693A (zh) * 2018-08-02 2020-02-14 北京万全德众医药生物技术有限公司 一种(s)(-)-氨磺必利的制备方法
JP2022535893A (ja) 2019-06-04 2022-08-10 サノビオン ファーマシューティカルズ インク 放出調節製剤およびその使用
USD1047552S1 (en) * 2021-04-23 2024-10-22 Krueger International, Inc. Furniture leg with frame
CN116003304A (zh) * 2023-02-08 2023-04-25 浙江皓华制药有限公司 一种氨磺必利的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (OSRAM) * 1973-09-25 1980-06-27 Ile De France
FR2299862B1 (en) * 1975-02-07 1978-07-21 Soc Et Scient Et Ind Substd. N-(1-benzylpyrrolidinyl-2-alkyl)benzamides - used as antiemetics, anti-ulcer agents and CNS active
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
IE42210B1 (en) * 1974-12-18 1980-06-18 Synthelabo 2-methoxy-benzamide derivatives

Also Published As

Publication number Publication date
PL212899A1 (OSRAM) 1980-01-14
JPS54145658A (en) 1979-11-14
AU528561B2 (en) 1983-05-05
IE47798B1 (en) 1984-06-27
PL118151B1 (en) 1981-09-30
IE790092L (en) 1979-07-20
GB2083458A (en) 1982-03-24
NL7900457A (nl) 1979-07-24
GR64431B (en) 1980-03-21
LU80786A1 (fr) 1979-09-07
CY1201A (en) 1983-12-31
DK20979A (da) 1979-07-21
ZM579A1 (en) 1979-12-21
EG14045A (en) 1983-09-30
AR221354A1 (es) 1981-01-30
AT377977B (de) 1985-05-28
YU5079A (en) 1983-06-30
US4401822A (en) 1983-08-30
RO76393A (ro) 1981-03-30
NL191707C (nl) 1996-04-02
NO790180L (no) 1979-07-23
BG31496A3 (bg) 1982-01-15
CS226181B2 (en) 1984-03-19
HU179793B (en) 1982-12-28
ES476755A1 (es) 1979-06-01
YU25483A (en) 1983-10-31
GB2083458B (en) 1983-03-09
FI71126C (fi) 1986-11-24
IT1164655B (it) 1987-04-15
IN150226B (OSRAM) 1982-08-21
GB2012765B (en) 1982-09-08
PH15725A (en) 1983-03-18
AR220574A1 (es) 1980-11-14
BE872585A (fr) 1979-06-07
AU4337379A (en) 1979-07-26
DK158346B (da) 1990-05-07
JPS6049192B2 (ja) 1985-10-31
CA1101430A (en) 1981-05-19
ZA79219B (en) 1980-01-30
PT69068A (fr) 1979-02-01
ATA39879A (de) 1983-12-15
SE8603773L (sv) 1986-09-09
US4294828A (en) 1981-10-13
NZ189378A (en) 1983-03-15
SE460968B (sv) 1989-12-11
MX5793E (es) 1984-07-19
FI790182A7 (fi) 1979-07-21
IL56411A0 (en) 1979-03-12
NO151320B (no) 1984-12-10
FR2415099A1 (fr) 1979-08-17
SU820659A3 (ru) 1981-04-07
IT7947706A0 (it) 1979-01-18
PH22287A (en) 1988-07-22
SE7900380L (sv) 1979-07-21
FI71126B (fi) 1986-08-14
DE2901181C2 (de) 1984-07-19
YU42172B (en) 1988-06-30
NL191707B (nl) 1995-12-01
GB2012765A (en) 1979-08-01
DK158346C (da) 1990-10-08
RO80311A (ro) 1982-12-06
DE2901181A1 (de) 1979-07-26
NO151320C (no) 1985-04-17
HK12184A (en) 1984-02-24
OA06156A (fr) 1981-06-30
SE8603773D0 (sv) 1986-09-09
ES477782A1 (es) 1979-09-16
PL116532B1 (en) 1981-06-30
DD141520A5 (de) 1980-05-07
MC1232A1 (fr) 1979-10-26
FR2415099B1 (OSRAM) 1981-02-20
CH637927A5 (fr) 1983-08-31
MX7623E (es) 1990-03-27
IL56411A (en) 1982-09-30
BG31497A3 (bg) 1982-01-15
YU41278B (en) 1986-12-31

Similar Documents

Publication Publication Date Title
SE448874B (sv) Derivat av 4-amino-5-alkylsulfonyl-orto-anisamider, farmakologisk komposition och sett att framstella amiderna
FI965020A0 (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
DK114783A (da) Hidtil ukendte forbindelser, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
FI104072B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(aryylioksialkyyli)heteroaryylipiperidiinien ja -heteroaryylipiperatsiinien valmistamiseksi
ATE18048T1 (de) Carbapenem-derivate, ihre herstellung und sie enthaltende zusammensetzungen.
FI942881A0 (fi) 2-piperatsinoniyhdisteet ja niiden käyttö
ATE152444T1 (de) N,n-disubstituierte amidsäuren, ihre ammoniumsalze sowie verwendung als emulgator
NO873000D0 (no) Fortykkende preparater for aminsyre.
DE69615707D1 (de) 1-benzolsulfonylpyrrolidinderivate als bradykinin rezeptor antagonisten
NO157895C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoksazol-derivater.
DK358983A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
ATE113594T1 (de) Verfahren zur herstellung von sulfonylharnstoff- derivaten.
FI871445A0 (fi) Foerfarande foer framstaellning av nya spergualinderivat.
IE791490L (en) Phenyl-alkanoic acids
ATE171936T1 (de) Salpetersäureester von 2-(2,6-dihalophenylamino) phenylacetoessigsäurederivaten und verfahren zu ihrer herstellung
DE69110107D1 (de) Verfahren zur Herstellung von 3-Alkoxymethyl Cephalosporinderivate.
IE821315L (en) PREPARATION OF 5,6,7,7a-TETRAHYDRO-4H-THIENO-£3,2-c|¹PYRIDIN-2-ONES
ATE107926T1 (de) Verfahren zur herstellung von isothiazolinonen durch cyclisierung.
ZA865260B (en) Derivatives of 4-oh quinoline carboxylic acid substituted at position 2 by a dihydroxylated group possibly etherified or esterified,the process and the intermediates for their preparation,their application as medicaments and the compositions containing them
ES8105007A1 (es) Un procedimiento para la preparacion de nuevos compuestos amidicos de penicilina
NO942048D0 (no) Fremgangsmåte for fremstilling av krystallinsk loracarbef-monohydrat
ES8200696A1 (es) Un procedimiento para la preparacion de nuevos compuestos amidicos de cefalosporina
IL59358A (en) Hydroxytetrahydro(phenoxymethyl)-imidazothiazole and thiazolopyrimidine derivatives,their preparation and pharmaceutical compositions containing them
SE7710933L (sv) 5-alkoxi-pikolinsyror
NO872006D0 (no) Fremgangsmaate for fremstilling av cefalosporinderivater.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7900380-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7900380-2

Format of ref document f/p: F